Kinase drug research has achieved significant progress in the field of targeted therapies, yet numerous new targets and indications remain under investigation.
Biochemical and cell-based screening platforms are crucial in kinase drug research. VKEY-BlO provides highly sensitive and high-throughput solutions for developing assayst o screening kinase candidate compounds.
VKEY-BIO offers over 300 GPCR cell lines, covering Gs, Gi, and Gq targets, as well as over 20 reporter gene cell lines, designed for GPCR research applications. Additionally, we provide cAMP detection kits and reporter gene assay kits to detect our cell lines.
Cell and gene therapy (CGT) involves utilizing cells or genetic material to treat diseases by correcting, replacing, or enhancing defective genes or cells within the body. VKEY-BIO offers a Dual Luciferase Detection Kit that can be used to assess the efficacy of gene editing or gene expression modulation techniques.
Immunology is pivotal in drug development, especially in immunotherapy and vaccine research, targeting cancer and autoimmune diseases. VKEY-BIO offers cytokines detection kits for Immunology cell-based assay research.
Biologics drug discovery is centered around the development of therapeutic drugs derived from biological sources, including proteins, antibodies, and nucleic acids, to address a wide range of diseases. VKEY-BIO provides Hybridoma screening kits, antibodies detection kits, and cytokines detection kits to support biologics drug discovery research.
ADC drug discovery focuses on developing targeted cancer therapies by combining monoclonal antibodies with potent cytotoxic drugs, with the aim of delivering the drug directly to cancer cells while minimizing harm to healthy tissue. VKEY-BIO offers a Cell Viability Detection Kit that can be used to assess the viability of cells treated with ADC drug interventions.
English
